Strategic partnership Potential collaboration with Evergreen Nephrology LLC through the joint venture announced in June 2022 offers a pathway to expand service coverage, share resources, and access larger referral networks within the Dallas-Fort Worth market.

Growth and scale Revenue size indicates mid-to-large practice with 201-500 employees and annual revenue between 50M and 100M, suggesting capacity for expanded service lines, ancillary offerings, and contract-based programs with payers or hospital systems.

Clinical leadership Having multiple physicians serving as directors of nephrology and transplant departments at major Dallas and Fort Worth hospitals signals strong institutional relationships and credibility to negotiate larger-site collaborations, IP/education programs, or telemedicine initiatives.

Technology adoption Existing tech stack includes cloud, SEO tools, forms, and web infrastructure. These can be leveraged for patient engagement platforms, data analytics partnerships, and digital marketing programs to attract referrals and improve patient retention.

Market positioning DNA is positioned as a national leader with a long history and comprehensive kidney care offerings, creating opportunities to sell advanced care services, transplant support, hypertension management programs, and integrated care bundles to health systems seeking kidney disease expertise.